Director/PDMR Shareholding

RNS Number : 9819Y

GlaxoSmithKline PLC

05 January 2011

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 31 December 2010, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depository Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2010:

GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment

Non-Executive Director	No. of Ordinary Shares	Average Price (£)	No. of ADSs	Average Price ($)
Sir Christopher Gent	2,658.67	12.55
Prof Sir Roy Anderson	300.96	12.55
Dr Stephanie Burns			268.56	39.18
Mr Lawrence Culp			958.86	39.18
Sir Crispin Davis	2,176.24	12.55
Sir Deryck Maughan			851.96	39.18
Mr James Murdoch	131.45	12.55
Dr Daniel Podolsky			429.75	39.18
Mr Tom de Swaan	469.75	12.55
Sir Robert Wilson	613.37	12.55

The Company and the Non-Executive Directors were informed of these allocations on 4 January 2011.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

5 January 2011

 

END

 

 

RDSQELFBFFFXBBE